5 completed. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
Follow Hepatitis C (HCV): new trials by email Literature Review of Hepatitis C (HCV) trials Research Report on Hepatitis C (HCV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection Faldaprevir, TD-6450, Ribavirin - Hepatitis C Viral Infection, Chronic Hepatitis C | Phase 2 | Completed | Trek Therapeutics, PBC | 25 | 2016-05-01 | 2017-10-17 |
| A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection Faldaprevir, TD-6450, Ribavirin - Hepatitis C Viral Infection, Chronic Hepatitis C | Phase 2 | Completed | Trek Therapeutics, PBC | 16 | 2015-10-01 | 2017-01-30 |
| Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults Ombitasvir/ABT-450/Ritonavir, Dasabuvir, Ribavirin (RBV) - Chronic Hepatitis C, Hepatitis C (HCV) | Phase 2 | Completed | AbbVie | 46 | 2015-06-01 | 2017-10-31 |
| Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases Naderin, Standard Therapy - Malignant Neoplasms, Tuberculosis (TB) | Phase 2 / Phase 3 | Completed | MIPO Clinic | 75 | 2013-05-15 | 2026-06-30 |
| ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients ABT-450, ABT-333, ABT-267 - Chronic Hepatitis C, Hepatitis C (HCV) | Phase 2 | Completed | AbbVie (prior sponsor, Abbott) | 580 | 2011-10-01 | 2015-04-22 |
Hepatitis C (5) · Hepatitis C, Chronic (4) · Neoplasms (1) · Neutropenia (1) · Tuberculosis (1)
Blood-Borne Infections (5) · Communicable Diseases (5) · Digestive System Diseases (5) · Flaviviridae Infections (5) · Hepatitis (5) · Hepatitis, Viral, Human (5) · Infections (5) · Liver Diseases (5) · RNA Virus Infections (5) · Virus Diseases (5) · Chronic Disease (4) · Disease Attributes (4) · Hepatitis, Chronic (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4)
Ribavirin (4) · dasabuvir (2) · faldaprevir (2) · Ritonavir (1) · Standard of Care (1) · ombitasvir (1) · paritaprevir (1) · sodium nucleinate (1)
Trek Therapeutics, PBC (2) · AbbVie (1) · AbbVie (prior sponsor, Abbott) (1) · MIPO Clinic (1)
United States (3) · New Zealand (2) · Australia (1) · Canada (1) · France (1) · Germany (1) · Puerto Rico (1) · Spain (1) · United Kingdom (1)
Tarek Hassanein, MD (2) · Daniel Cohen, MD (1) · Ed Gane, MD (1) · Emily Dumas, PhD (1)
2014 (1)